Keith Orford - Jan 25, 2022 Form 4 Insider Report for Calithera Biosciences, Inc. (CALA)

Role
Director
Signature
/s/ Keith Orford
Stock symbol
CALA
Transactions as of
Jan 25, 2022
Transactions value $
$0
Form type
4
Date filed
1/27/2022, 03:13 PM
Previous filing
Nov 12, 2021
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CALA Employee Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 25, 2022 Common Stock 40K $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Option is initially subject to vesting pursuant to the Company's 2014 Equity Incentive Plan. The Option will vest in monthly installments as measured from November 18, 2021 over three years, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer. In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction.